PATENT CLAIM ANALYSIS

Application Number: 16028209
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-10
Patent Classification: ["514", "021300"]

Abstract:
Several embodiments of the present disclosure relate to glycotargeting therapeutics that are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.

Claim (Index 1):
A composition comprising a compound of Formula 1:\n X\ue8a0Y-Z] m \u2003\u2003 Formula 1 \n where:\n m is an integer from about 1 to 100; \n X comprises an antigen against which a patient develops an unwanted immune response, or a tolerogenic portion thereof; \n Y comprises a linker moiety; and \n Z comprises a liver-targeting moiety.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 95.0
- Lexical Diversity: 1.44898
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15185564', '14649902', '14417487', '15316124', '14460768']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.723232804279979
- 35 USC 102 Novelty (BERT): 0.6089330446902036
- Combined Prediction Score: 0.7118028283210016
- Mean Citation Score: 253.141822
- Max Citation Score: 577.1974
- Similarity Product: 469.7679557588816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test